{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_2836", "batch_size": 200, "batch_pos": 109, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment states the company is 'in discussions', which is a neutral statement.", "method": "llm_batch", "batch_id": "batch_2_11880", "batch_size": 200, "batch_pos": 92, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "Segment does not contain a moderate verb paired with significant scale or impact.", "method": "llm_batch", "batch_id": "batch_3_14172", "batch_size": 200, "batch_pos": 23, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_11384", "batch_size": 200, "batch_pos": 20, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "Reports discussions; lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_6516", "batch_size": 200, "batch_pos": 17, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser token.", "method": "llm_batch", "batch_id": "batch_6_7996", "batch_size": 200, "batch_pos": 178, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "No bare negation present.", "method": "llm_batch", "batch_id": "batch_7_2972", "batch_size": 200, "batch_pos": 162, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Moderna confirming discussions regarding a capability ('in discussions with the U.S. government on advancing our pandemic flu candidate'). No explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_13968", "batch_size": 200, "batch_pos": 133, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
